Product Description: Quercetin GMP is Quercetin (HY-18085) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Quercetin is a flavonoid antioxidant, a PI3K inhibitor and a SIRT1 Activator[1][2][3][4][5][6].
Formula: C15H10O7
Citations: Mol Carcinog. 2024 Aug 22./Adv Funct Mater. 27 January 2022./Aging (Albany NY). 2021 Nov 25;13(22):24753-24767./Aging. 2020 Jun 25;12(12):11337-11348./Antioxidants (Basel). 2022 Feb 14;11(2):385./Antioxidants (Basel). 2022 Nov 11;11(11):2222./Antioxidants (Basel). 2024 Jul 29;13(8):918./Behav Brain Res. 2022 Dec 16;114260./Biogerontology. 2022 Apr 25:1-15./Biology (Basel). 2024 Aug 29./Biomed Pharmacother. 2024 Apr 25:175:116606./Biomed Res Int. 23 Jul 2022./Bioresour Bioprocess. 2024 Nov 27;11(1):108./bioRxiv. 2023 Dec 20./bioRxiv. 2024 Jul 30:2024.07.29.605645./BMC Complement Med Ther. 2023 Dec 1;23(1):433./BMC Complement Med Ther. 2023 Mar 23;23(1):89./Breast Cancer. 2024 Dec 20:16:993-1004./Cell Mol Gastroenterol Hepatol. 2022 Apr 2;14(1):75-99./Chem Biol Drug Des. 2024 Apr;103(4):e14520./Chem Biol Interact. 2024 May 19:396:111064./Chin J Integr Med. 2022 Nov 14;1-8./Chin Med. 2024 Mar 18;19(1):48./Comput Struct Biotechnol J. 1 October 2021./Ecotoxicol Environ Saf. 2024 Sep 30:285:117136./Environ Pollut. 25 August 2021, 118036./Eur J Med Chem. 2018 Mar 25;148:63-72. /Eur J Med Res. 2022 Dec 15;27(1):292./Evid Based Complement Alternat Med. 2022 May 9;2022:2256671./Evid-Based Compl Alt. 26 Aug 2021./Exp Cell Res. 2020 Aug 1;393(1):112054./Exp Eye Res. 2022 Aug 2;223:109207./Exp Eye Res. 2023 Feb 15;109416./Exp Ther Med. 2021 Mar 8./Food Chem Toxicol. 2024 Jul 23:114877./Food Chem. 2022: 134807./Free Radic Biol Med. 2024 Jan 6:S0891-5849(24)00002-9./Front Cardiovasc Med. 2022; 9: 804801./Front Oncol. 2022 Aug 10;12:882784./Genomics. 2021 Jun 7;S0888-7543(21)00220-2./Heliyon. 2024 Jul 31./Heliyon. 2024 Sep 20;10(19):e38122./Immunobiology. 2022 Dec 30;228(2):152324./Immunobiology. 2022: 152324./Inflamm Res. 2020 Dec;69(12):1201-1213./Inflammopharmacology. 2024 Dec 6./Inflammopharmacology. 2024 Nov 20./Insects. 2018 Jun 29;9(3). pii: E77. /Int Immunopharmacol. 2024 Nov 2;143(Pt 3):113546./Int Immunopharmacol. 2024 Sep 27;142(Pt B):113162./Int J Insect Sci. 2018 Feb 28;10:1179543318758409./Int J Mol Med. 2023 Dec;52(6):116./Int J Mol Med. 2025 Jan;55(1):4./Int J Mol Sci. 2024 Apr 4;25(7):4031./Int J Mol Sci. 2024 Jul 7;25(13):7461./International Journal of Human Anatomy. 2020 Dec./Invest Ophthalmol Vis Sci. 2024 Nov 4;65(13):11./J Agric Food Chem. 2020 Jul 29;68(30):8050-8056./J Agric Food Chem. 2023 May 3./J Agric Food Chem. 2024 Mar 27;72(12):6651-6659./J Anim Sci Biotechnol. 2024 Dec 8;15(1):168./J Anim Sci Biotechnol. 2024 Sep 5;15(1):119./J Ethnopharmacol. 2024 Jul 11:118576./J Food Biochem. 2024 Aug 28./J Funct Foods. 2024 Aug./J Inflamm Res. 2021 Dec 7;14:6601-6618./J Mol Liq. 23 November 2021, 118164./J Periodontal Res. 2023 Aug 3./JCI Insight. 2025 Jan 23;10(2):e180248./Journal of Traditional Chinese Medical Sciences. 2024 Jun 12./Life Sci. 2020 Sep 15;257:118116./Medicine. 2023 Oct 13;102(41):e35384./Mol Med Rep. 2024 Feb;29(2):26./Mol Med Rep. 2025 Mar;31(3):60./Molecules. 2020 Apr 23;25(8):1980./Molecules. 2023 Mar 23./Nat Aging. 2024 Apr;4(4):527-545./Nat Commun. 2025 Jan 6;16(1):424./Naunyn Schmiedebergs Arch Pharmacol. 2023 May 6./Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr 2./Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug 2./Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun 18./Osteoarthritis Cartilage. 2021 Mar;29(3):413-422./Oxid Med Cell Longev. 05 Sept 2022./Pharmacological Research-Modern Chinese Medicine. 2024 Mar, 10, 100360./Plant Foods Hum Nutr. 2022 Aug 20./Plant Methods. 2022 Jun 23;18(1):87./PLoS One. 2024 Jul 11;19(7):e0305612./Research Square Preprint. 2021. Jul./Research Square Preprint. 2024 Dec 13./Respir Res. 2024 Aug 2;25(1):294./Sci Rep. 2024 Jun 20;14(1):14183./Thorac Cancer. 2021 Mar 11./Tissue Eng Regen Med. 2024 Jul 26./Virus Res. 2021 Sep 4;198556./World J Stem Cells. 2023 Aug 26; 15(8): 842-865.
References: [1]Zhou C, Lin Y. Osteogenic differentiation of adipose-derived stem cells promoted by quercetin. Cell Prolif. 2014 Apr;47(2):124-32./[2]Wattel A, et al. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem. 2004 May 15;92(2):285-95./[3]Zhou Y, et al. The Effect of Quercetin on the Osteogenesic Differentiation and Angiogenic Factor Expression of Bone Marrow-Derived Mesenchymal Stem Cells. PLoS One. 2015 Jun 8;10(6):e0129605./[4]Woo JT, et al. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Biol Pharm Bull. 2004 Apr;27(4):504-9./[5]Kim YJ, et al. Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem Pharmacol. 2006 Nov 15;72(10):1268-78./[6]Pang XG, et al. Quercetin Stimulates Bone Marrow Mesenchymal Stem Cell Differentiation through an Estrogen Receptor-Mediated Pathway. Biomed Res Int. 2018 Mar 15;2018:4178021.
CAS Number: 117-39-5
Molecular Weight: 302.24
Compound Purity: 99.7
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Apoptosis;Autophagy;Mitophagy;PI3K;Reactive Oxygen Species
English
Deutsch
